Sign In
Buy BAYRY
$9.92
+0.0400 (+0.405%)
At Close: Jun 03, 2026
Bayer Getting Past Litigation of Roundup
02:36pm, Tuesday, 28'th Sep 2021
German blue-chip Bayer AG ( BAYRY , Financial) has really gotten beaten up with its multibillion-dollar litigation payouts of Roundup. The stock is at a multiyear low, but it looks like the litigation
BWXT Medical, Bayer AG Ink Agreement On Actinium-225
10:24am, Thursday, 16'th Sep 2021
Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at [email protected] Trending
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today that detailed results from the Phase III FIGARO-DKD study demonstrated that compared with placebo, KERENDIA® (finerenone) – a first-in-class n
Bayer: Still A Bargain Despite Ongoing Legal Challenges
07:48am, Thursday, 26'th Aug 2021
Bayer is still in a downtrend with the legal battle going on and a settlement still unclear.
CardieX expands chronic kidney disease clinical trial agreement with Bayer
11:04pm, Tuesday, 24'th Aug 2021
CardieX Ltd has secured a second material expansion to its clinical trial with global pharmaceutical company Bayer AG. Via subsidiary ATCOR, the ASX-listed health technology company inked amendments w
Bayer asks US Supreme Court to reverse Roundup damages for man with cancer
01:12pm, Monday, 16'th Aug 2021
Bayer on Monday said it filed a petition with the U.S. Supreme Court to reverse court verdicts that awarded damages to a customer blaming his cancer on use of the German group's glyphosate-based weedk
Bayer takes legal battle over glyphosate cancer claims to U.S. supreme court
10:44am, Monday, 16'th Aug 2021
Bayer on Monday said it filed a petition with the U.S. Supreme Court to reverse court verdicts that awarded damages to a customer blaming his cancer on use of the German group's glyphosate-based weedk
Berkeley Lights, Bayer Ink Discovery Pact For Next-Gen Traits In Agricultural Sector, Berkeley Q2 Earnings Miss Estimates
08:03am, Wednesday, 11'th Aug 2021
Berkeley Lights Inc (NASDAQ: BLI) reports Q2 sales of $19.3 million, +82% Y/Y, but slightly missing the consensus of $19.64 million. The Company expanded the installed base to 92 platforms, with sev
3 Pharma Stocks to Buy in August
06:04am, Wednesday, 11'th Aug 2021
These stocks offer solid growth opportunities.
Bayer loses third appeals case over glyphosate weedkiller
05:24am, Tuesday, 10'th Aug 2021
Bayer lost a third appeal against U.S. court verdicts that awarded damages to customers blaming their cancers on use of its glyphosate-based weedkillers, leaving the German drugs and pesticides group
Bayer's (BAYZF) CEO Werner Baumann on Q2 2021 Results - Earnings Call Transcript
02:30pm, Thursday, 05'th Aug 2021
Bayer's (BAYZF) CEO Werner Baumann on Q2 2021 Results - Earnings Call Transcript
Bayer Sees A Golden Age For China's Pharmaceutical Market
05:02am, Thursday, 05'th Aug 2021
New medicines target an aging yet increasingly well-off country
Bayer lifts 2021 view as second-quarter loss narrows
02:23am, Thursday, 05'th Aug 2021
Bayer lifts 2021 view as second-quarter loss narrows
Bayer raises outlook after strong Q2
01:52am, Thursday, 05'th Aug 2021
Bayer on Thursday lifted its outlook for 2021, citing double digit growth rates at all divisions during the second-quarter, most notably its pharmaceuticals unit.
Bayer buys biopharma firm Vividion Therapeutics for up to $2 billion
01:45am, Thursday, 05'th Aug 2021
Bayer on Thursday said it acquired U.S.-based biopharmaceuticals company Vividion Therapeutics for up to $2 billion to boost its ability to discover new treatments and lift the value of its drug pipel
